ATE478941T1 - Vorläuferzellen aus der wharton sulze von humanen nabelschnüren - Google Patents

Vorläuferzellen aus der wharton sulze von humanen nabelschnüren

Info

Publication number
ATE478941T1
ATE478941T1 AT04709560T AT04709560T ATE478941T1 AT E478941 T1 ATE478941 T1 AT E478941T1 AT 04709560 T AT04709560 T AT 04709560T AT 04709560 T AT04709560 T AT 04709560T AT E478941 T1 ATE478941 T1 AT E478941T1
Authority
AT
Austria
Prior art keywords
wharton
julk
human umbilical
cells
umbilical cords
Prior art date
Application number
AT04709560T
Other languages
English (en)
Inventor
John E Davies
Dolores Baksh
Rahul Sarugaser
Morris Hosseini
Antony David Sutton Lickorish
Original Assignee
John E Davies
Dolores Baksh
Rahul Sarugaser
Morris Hosseini
Antony David Sutton Lickorish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John E Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony David Sutton Lickorish filed Critical John E Davies
Application granted granted Critical
Publication of ATE478941T1 publication Critical patent/ATE478941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT04709560T 2003-02-11 2004-02-10 Vorläuferzellen aus der wharton sulze von humanen nabelschnüren ATE478941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44627503P 2003-02-11 2003-02-11
PCT/CA2004/000182 WO2004072273A1 (en) 2003-02-11 2004-02-10 Progenitor cells from wharton's jelly of human umbilical cord

Publications (1)

Publication Number Publication Date
ATE478941T1 true ATE478941T1 (de) 2010-09-15

Family

ID=32869477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04709560T ATE478941T1 (de) 2003-02-11 2004-02-10 Vorläuferzellen aus der wharton sulze von humanen nabelschnüren

Country Status (14)

Country Link
US (5) US7547546B2 (de)
EP (2) EP2277992A3 (de)
JP (1) JP4790592B2 (de)
KR (1) KR101077760B1 (de)
AT (1) ATE478941T1 (de)
AU (2) AU2004210891B2 (de)
BR (1) BRPI0407221A (de)
CA (1) CA2515469C (de)
DE (1) DE602004028803D1 (de)
ES (1) ES2351386T3 (de)
HK (1) HK1084417A1 (de)
IL (2) IL170221A (de)
PT (1) PT1594957E (de)
WO (1) WO2004072273A1 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US7045148B2 (en) 2000-12-06 2006-05-16 Anthrogenesis Corporation Method of collecting placental stem cells
WO2002063962A1 (en) * 2001-02-14 2002-08-22 Hariri Robert J Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
WO2002064755A2 (en) * 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
AU2004210891B2 (en) 2003-02-11 2008-09-25 Dolores Baksh Progenitor cells from Wharton's jelly of human umbilical cord
US8491883B2 (en) 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
CA2530421C (en) 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
JP2007508018A (ja) 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
EP1789534B1 (de) * 2004-08-16 2014-08-06 CellResearch Corporation Pte Ltd Isolierung von stamm-/progenitorzellen aus der amnionmembran der nabelschnur
WO2006101548A2 (en) * 2004-12-21 2006-09-28 Ethicon, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
WO2006083394A2 (en) * 2004-12-21 2006-08-10 Ethicon, Inc. Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) * 2004-12-21 2006-07-13 Agnieszka Seyda Tissue engineering devices for the repair and regeneration of tissue
EP1838842A2 (de) * 2004-12-23 2007-10-03 Ethicon, Incorporated Behandlung osteochondraler krankheiten unter verwendung postpartum gewonnener zellen und von produkten davon
WO2006071777A2 (en) * 2004-12-23 2006-07-06 Ethicon Incorporated Soft tissue repair and regeneration using postpartum-derived cells and cell products
ES2621847T3 (es) * 2004-12-23 2017-07-05 DePuy Synthes Products, Inc. Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
CA2592435C (en) 2004-12-23 2017-03-28 Ethicon, Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
AU2006304277B2 (en) 2005-10-13 2012-07-05 Celularity Inc. Immunomodulation using placental stem cells
US20090170059A1 (en) * 2005-11-14 2009-07-02 Hans Klingemann Methods for Preparing Cord Matrix Stem Cells (CMSC) for Long Term Storage and for Preparing a Segment of umbilical cord for cryopreservation
ES2642844T3 (es) 2005-12-16 2017-11-20 DePuy Synthes Products, Inc. Composiciones y métodos para inhibir una respuesta inmune adversa en el trasplante de histocompatibilidad que no coinciden
ES2391034T3 (es) * 2005-12-19 2012-11-20 Ethicon, Inc. Expansión in vitro de células derivadas postparto en frascos rotatorios
KR20140146220A (ko) 2005-12-22 2014-12-24 제인 에니스 동결된 제대조직으로부터 유래하는 생존가능한 세포
AU2006330409B2 (en) * 2005-12-28 2012-07-19 Ethicon, Incorporated Treatment of peripheral vascular disease using postpartum-derived cells
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
EP2412801A1 (de) 2005-12-29 2012-02-01 Anthrogenesis Corporation Co-Kultivierung von Plazentastammzellen und Stammzellen aus einer zweiten Quelle
PT2471904T (pt) 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
CA2644508A1 (en) * 2006-03-01 2007-09-07 The Regenerative Medicine Institute Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
PT2029149T (pt) * 2006-05-05 2017-08-23 Tissue Regeneration Therapeutics Inc Células progenitoras imunopriviligiadas e moduladoras
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
WO2007146106A2 (en) * 2006-06-05 2007-12-21 Cryo- Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
MX2008015645A (es) * 2006-06-09 2009-02-06 Anthrogenesis Corp Nicho placentario y uso de este para cultivar celulas primordiales.
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008060037A1 (en) * 2006-11-15 2008-05-22 Seoul National University Industry Foundation Method for the simultaneous primary-isolation and expansion of endothelial stem/progenitor cell and mesenchymal stem cell derived from mammal including human umbilical cord
KR100902569B1 (ko) * 2007-01-19 2009-06-11 재단법인서울대학교산학협력재단 인간 탯줄 유래 중간엽 줄기세포 및 이의 확립방법
AU2007332799A1 (en) * 2006-12-07 2008-06-19 Teva Pharmaceutical Industries Ltd. Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
NZ578819A (en) 2007-02-12 2012-02-24 Anthrogenesis Corp Treatment of inflammatory diseases using placental stem cells
WO2009021333A1 (en) * 2007-08-14 2009-02-19 Tissue Regeneration Therapeutics Inc. Blood vessel extraction from umbilical cord
US10925903B2 (en) 2007-09-13 2021-02-23 Reprobiogen Inc. Use of cells derived from first trimester umbilical cord tissue
CA2630708C (en) * 2007-09-13 2017-08-01 Clifford L. Librach Method of isolation and use of cells derived from first trimester umbilical cord tissue
CA3018281C (en) 2007-09-28 2022-02-22 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
ES2525718T3 (es) * 2007-10-05 2014-12-29 DePuy Synthes Products, LLC Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano
AU2008329653A1 (en) * 2007-11-28 2009-06-04 Organogenesis, Inc. Bioengineered tissue constructs and methods for production and use
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
US9005599B2 (en) 2008-04-21 2015-04-14 Tissue Regeneration Therapeutics Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US8828376B2 (en) 2008-08-20 2014-09-09 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
RU2662676C1 (ru) 2008-08-20 2018-07-26 Антродженезис Корпорейшн Улучшенная клеточная композиция и способы ее получения
RU2011110736A (ru) 2008-08-22 2012-09-27 Антродженезис Корпорейшн (Us) Способы и композиции для лечения костных дефектов с помощью плацентарных клеточных популяций
MX2011005229A (es) 2008-11-19 2011-06-16 Anthrogenesis Corp Celulas adherentes derivadas del amnios.
WO2010071864A1 (en) 2008-12-19 2010-06-24 Ethicon, Incorporated Treatment of lung and pulmonary diseases and disorders
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
US8771677B2 (en) 2008-12-29 2014-07-08 Vladimir B Serikov Colony-forming unit cell of human chorion and method to obtain and use thereof
BRPI1013409A2 (pt) * 2009-03-26 2018-01-16 Advanced Tech And Regenerative Medicine Llc células de tecido de cordão umbilical humano como terapia para doença de alzheimer
SG181774A1 (en) * 2009-12-18 2012-07-30 Lifeline Cord Blood Bank Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue
SG182508A1 (en) * 2010-01-14 2012-08-30 Organogenesis Inc Bioengineered tissue constructs and methods for producing and using thereof
EP2529007B1 (de) 2010-01-26 2017-07-12 Anthrogenesis Corporation Behandlung von knochenbedingten karzinomen mit plazentastammzellen
AU2010350075B2 (en) 2010-03-30 2016-03-03 Histocell, S.L. New biomaterial from Wharton's jelly umbilical cord
LT2556145T (lt) 2010-04-07 2016-11-10 Anthrogenesis Corporation Angiogenezė naudojant placentos kamienines ląsteles
CA2795401A1 (en) 2010-04-08 2011-10-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
CA2801009C (en) 2010-06-01 2021-10-26 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
JP5996533B2 (ja) 2010-07-13 2016-09-21 アントフロゲネシス コーポレーション ナチュラルキラー細胞を生成させる方法
US9057734B2 (en) 2010-08-23 2015-06-16 President And Fellows Of Harvard College Optogenetic probes for measuring membrane potential
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
PL2714059T3 (pl) 2011-06-01 2019-04-30 Celularity Inc Leczenie bólu z użyciem komórek macierzystych łożyska
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
PT2775928T (pt) 2011-11-08 2019-05-30 Auxocell Laboratories Inc Sistemas e métodos para processar células
US9611513B2 (en) 2011-12-23 2017-04-04 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue derived cells
DK3321355T3 (da) 2011-12-30 2021-11-08 Amit Patel Fremgangsmåder og sammensætninger til klinisk afledning af en allogen celle og terapeutiske anvendelser
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
CA2868485C (en) 2012-03-28 2020-09-15 Michael R. Ladisch Methods and systems useful for foodborne pathogen detection
US9670457B2 (en) * 2012-05-08 2017-06-06 Stem Cell Reserve Lp Stem cells and matrix from cord tissue
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
JP2016506968A (ja) 2013-02-05 2016-03-07 アントフロゲネシス コーポレーション 胎盤由来のナチュラルキラー細胞
US10731132B2 (en) 2013-03-15 2020-08-04 Amniotics Ab Methods and apparatuses for umbilical cord blood collection and isolation of cells
US10400211B1 (en) 2014-04-28 2019-09-03 Donnie Rudd Cell composition for tissue regeneration
US9993748B2 (en) 2014-08-11 2018-06-12 Auxocell Laboratories, Inc. Centrifuge clip and method
USD748462S1 (en) 2014-08-11 2016-02-02 Auxocell Laboratories, Inc. Centrifuge clip
US10542743B2 (en) 2015-01-05 2020-01-28 Hygieia Therapeutics Sdn Bhd Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells
EP3352771B1 (de) 2015-09-23 2021-03-24 Osiris Therapeutics, Inc. Nabelschnurgewebezusammensetzungen und verfahren zur verwendung
WO2018073615A1 (en) 2016-10-21 2018-04-26 Longboat Explorers Ab Methods and compositions for generating hematopoietic cells
CN111727238B (zh) * 2017-10-27 2024-06-25 阿里斯制药有限公司 非人动物胎儿组织提取物、生产提取物的方法及其用途
CN111492051B (zh) * 2017-12-22 2024-02-23 奇斯药制品公司 间充质基质细胞以及从脐带获得间充质基质细胞的方法
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
US20210269768A1 (en) 2018-07-02 2021-09-02 Vetbiobank Neonatal stromal cells having low mhc-i expression and uses therof
WO2021003254A1 (en) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Cryopreservation medium comprising a tissue extract
US20220372444A1 (en) 2019-10-18 2022-11-24 Amniotics Ab Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof
EP3909593A1 (de) 2020-05-15 2021-11-17 Rigshospitalet Stammzellen zur behandlung von hautläsionen
EP4405375A1 (de) 2021-09-23 2024-07-31 President and Fellows of Harvard College Genetisch codierte spannungsindikatoren und verwendungen davon
WO2023223303A1 (en) 2022-05-20 2023-11-23 Alt Atlas Ltd. Novel cell lines and systems and methods for a machine learning manufacturing software platform that optimize unique functional ingredients and solutions for the biotech and foodtech industries

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578743B3 (fr) * 1985-03-13 1987-06-12 Bontemps Raymond Procede de fabrication d'une preparation medicamenteuse a base de substance mesenchymateuse du type microsepteurs
SU1708328A1 (ru) * 1989-07-11 1992-01-30 Кемеровский государственный медицинский институт Способ изготовлени сосудистого протеза
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US20050158289A1 (en) * 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) * 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
CA2381292C (en) * 1999-08-05 2016-05-24 Mcl Llc Multipotent adult stem cells and methods for isolation
US20020045260A1 (en) * 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
EP1383869B1 (de) 2001-04-24 2009-06-10 Dolores Baksh Vorläuferzellpopulationen, deren expansion und die entstehung von nicht-hämatopoetischen zelltypen daraus
US20030161818A1 (en) * 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
US7736892B2 (en) * 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
AU2004210891B2 (en) 2003-02-11 2008-09-25 Dolores Baksh Progenitor cells from Wharton's jelly of human umbilical cord
WO2005001081A1 (en) * 2003-06-27 2005-01-06 UNIVERSITé LAVAL Method of isolating cells from umbilical cord
CA2530421C (en) 2003-06-27 2015-04-21 Ethicon, Incorporated Repair and regeneration of ocular tissue using postpartum-derived cells
WO2005085428A1 (en) 2004-03-05 2005-09-15 Davies John E Serum-free suspension culture system for mesenchymal progenitor cells
KR20140146220A (ko) 2005-12-22 2014-12-24 제인 에니스 동결된 제대조직으로부터 유래하는 생존가능한 세포
CA2644508A1 (en) 2006-03-01 2007-09-07 The Regenerative Medicine Institute Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
PT2029149T (pt) 2006-05-05 2017-08-23 Tissue Regeneration Therapeutics Inc Células progenitoras imunopriviligiadas e moduladoras

Also Published As

Publication number Publication date
KR20050115862A (ko) 2005-12-08
US9611456B2 (en) 2017-04-04
US20170157180A1 (en) 2017-06-08
DE602004028803D1 (de) 2010-10-07
US8481311B2 (en) 2013-07-09
US9567564B2 (en) 2017-02-14
AU2004210891A1 (en) 2004-08-26
KR101077760B1 (ko) 2011-10-27
IL170221A (en) 2010-11-30
PT1594957E (pt) 2010-11-30
EP1594957B1 (de) 2010-08-25
US20090269318A1 (en) 2009-10-29
AU2008261123A1 (en) 2009-01-15
US20130259840A1 (en) 2013-10-03
IL202331A (en) 2011-08-31
EP2277992A2 (de) 2011-01-26
JP2006517102A (ja) 2006-07-20
US7547546B2 (en) 2009-06-16
EP2277992A3 (de) 2011-03-02
HK1084417A1 (en) 2006-07-28
CA2515469C (en) 2013-12-17
JP4790592B2 (ja) 2011-10-12
US20160032241A1 (en) 2016-02-04
US20050148074A1 (en) 2005-07-07
BRPI0407221A (pt) 2006-01-31
WO2004072273A1 (en) 2004-08-26
EP1594957A1 (de) 2005-11-16
AU2004210891B2 (en) 2008-09-25
ES2351386T3 (es) 2011-02-03
CA2515469A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
ATE478941T1 (de) Vorläuferzellen aus der wharton sulze von humanen nabelschnüren
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
DE60044793D1 (de) In-vitro Herstellung von transplantierbarem Knorpelgewebe
ATE193729T1 (de) Geminivirus-basiertes-genexpressionsystem
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
WO2004047747A3 (en) Compositions and methods for cell dedifferentiation and tissue regeneration
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
ES2056854T3 (es) Tiadiazinonas.
BR0211079A (pt) Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas
ATE459360T1 (de) Phosphoantigen enthaltene zusammensetzungen zur regulierung von immunereaktionen
NO20052505L (no) Ny bruk av dextran-sulfat
ATE402002T1 (de) Elektroverarbeitetes kollagen
FR09C0067I2 (fr) Agents contenant de l'acide carboxylique et leur utilisation dans la culture de plantes
BRPI0412871A (pt) combinações de substáncias ativas fungicidas
WO2005056755A3 (en) Compositions and methods for propagation of neural progenitor cells
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
ATE501635T1 (de) Chemische hemmstoffe des mismatch-repair
EP1501465A4 (de) Vektoren mit beiden isoformen von beta-hexosaminidase
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
ATE319681T1 (de) Herstellung von 4,4'-diketo-beta-karotenderivaten
DE60040860D1 (de) Mechanisch verlängerte neuronale zellen und methoden zur herstellung und verwendung dieser zellen
DK1366367T3 (da) Organtransplantatafstödning og tilknyttede tilstande
ATE468319T1 (de) M-diaminobenzole und deren säureaddukte sowie deren verwendung in färbemitteln
AU2012227326C1 (en) Progenitor cells from wharton's jelly of human umbilical cord
Eng et al. Effects of sunlight on encapsulated sprayable codling moth pheromone

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties